DGIST faculty start-up CTCELLS, selected for '200 Baby Unicorns Fostering Project'
(DGIST (Daegu Gyeongbuk Institute of Science and Technology)) CTCELLS, established by Professor Minseok Kim of the Department of New Biology, DGIST, was selected for the '200 Baby Unicorns Fostering Project' organized by Ministry of SMEs and Startups (MSS) and Korea Institute of Startup& Entrepreneurship Development (KISED). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
USC study shows inherited risk of early-onset cancer is higher among minority families
This study demonstrates the need for increased scrutiny on familial cancer clustering in minority populations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
NCRI to offer new opportunities for early career researchers
(National Cancer Research Institute) NCRI has created an Early Career Researcher Forum, which will enable early career researchers to build collaborative networks in their field of interest whilst enhancing their skills and supporting career development through training, mentoring, networking and research involvement opportunities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
Targeted tumors attack not-innocent bystanders
(Rice University) Antibody-drug conjugates developed are found to attack not only targeted tumor cells but also nontargeted 'bystanders.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
Racism and segregation associated with advanced stage lung cancers among blacks
(Boston University School of Medicine) Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 80-85% cases of lung cancer and when diagnosed early, has a five-year survival rate of 50-80%. Black patients have lower overall incidence of NSCLC than white patients, but are more likely to be diagnosed at later stages. They also are less likely to receive surgery for early-stage cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
How pancreatic cancer cells dodge drug treatments
(Cold Spring Harbor Laboratory) Pancreatic cancer cells typically rely on a mutant version of the KRAS protein to proliferate. These cancer cells can also survive losing KRAS by activating alternative growth pathways. CSHL scientists discovered a new interaction between mutant KRAS and a protein complex called RSK1/NF1 that may be the source of this adaptive resistance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
Investigating a better treatment sequence for esophageal cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcome for patients with esophageal cancer. As they await the results of a group of clinical trials, McCarter and other CU researchers looked at data from the National Cancer Database to identify other patients who have undergone the new sequence, and what the outcomes for those patients were. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
Study finds common protein in blood enables human fertilization and fighting infection
(University of California - Irvine) A new University of California, Irvine-led study reveals albumin (Alb), among the most abundant proteins in the body, activates a proton channel (hHv1), also widespread in the body, giving sperm the ability to penetrate and fertilize an egg, and allowing white blood cells to secrete large amounts of inflammatory mediators to fight infection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
(Medical University of South Carolina) In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries. Using a combination of personal passion and expertise, Klauber-DeMore shifted her knowledge of the pro-angiogenic protein SFRP2 in breast cancer to address the lack of treatment options for patients with aggressive metastatic osteosarcoma. The results of the combination treatment with SFRP2 and PD-1 antibodies in a preclinical model were published in Cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
How the surfaces of silicone breast implants affect the immune system
(Massachusetts Institute of Technology) A team led by MIT researchers analyzed how the surface topography on silicone breast implants influences health complications such as scarring, inflammation, and a rare type of lymphoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
Understanding the impact of medical cannabis on kids, a meta-analysis
(The Hebrew University of Jerusalem) Medical cannabis is particularly helpful at treating severe epilepsy and chemotherapy's pernicious side effects. However, the side effects of these treatments in kids is still an open question. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
University of Louisville receives $11.3 million from NIH for liver research center
(University of Louisville) The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence has received $11.3 million in funding from the National Institutes of Health to support its research into liver-related illness for an additional five years. The center supports leading-edge research with the goal of reducing the impact of many types of liver illness through prevention and the development of therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
Perspectives for future tumor therapy
(GSI Helmholtzzentrum f ü r Schwerionenforschung GmbH) It could become a breakthrough for future tumor treatments with heavy ions and pave new ways: In the current experiment period FAIR-Phase 0, the GSI Helmholtzzentrum f ü r Schwerionenforschung and the future accelerator center FAIR succeeded in performing a carbon ion FLASH experiment for the first time. The scientists involved were able to achieve the very high dose rates required and to irradiate tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
ESMO Gynaecological Cancers Virtual Congress 2021
(European Society for Medical Oncology) The first edition of the ESMO Gynaecological Cancers Congress will be held as a virtual meeting on 25-26 June 2021 and will focus on ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
Targeted therapy could be first line treatment for childhood cancer
(Newcastle University) Scientists studying a common childhood cancer have made a major breakthrough which could lead to a cure for some youngsters who would not have survived the condition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
